GH Research Stock (NASDAQ: GHRS) stock price, news, charts, stock research, profile.
Open | $11.25 |
Close | $11.48 |
Volume / Avg. | 10.39K / 44.57K |
Day Range | $11.06 - $11.64 |
52 Wk Range | 5.05 - 14.99 |
Market Cap | $520.28M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 9.76% |
Days to Cover | 36.41 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of GH Research (NASDAQ:GHRS) through any online brokerage.
Other companies in GH Research’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA) and SNDL (NASDAQ:SNDL).
GH Research has a consensus price target of $41.80.
The stock price for GH Research (NASDAQ: GHRS) is $10 last updated August 16, 2024 at 4:02 PM EDT.
There are no upcoming dividends for GH Research.
GH Research’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for GH Research.
GH Research is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.